R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, March 202... March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.
Digital Changing Faces: Digital and supplier, March 2026 Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
R&D Changing Faces: Pharma and biotech, March 2026 A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.
R&D Changing Faces: Board of Directors and Advisory Boards, Febr... Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, February ... February was a light month for agency and consultancy news, but a few interesting changes came through.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
